449 related articles for article (PubMed ID: 10852344)
1. Optimization of cationic lipid/DNA complexes for systemic gene transfer to tumor lesions.
Anwer K; Kao G; Proctor B; Rolland A; Sullivan S
J Drug Target; 2000; 8(2):125-35. PubMed ID: 10852344
[TBL] [Abstract][Full Text] [Related]
2. Ultrasound enhancement of cationic lipid-mediated gene transfer to primary tumors following systemic administration.
Anwer K; Kao G; Proctor B; Anscombe I; Florack V; Earls R; Wilson E; McCreery T; Unger E; Rolland A; Sullivan SM
Gene Ther; 2000 Nov; 7(21):1833-9. PubMed ID: 11110415
[TBL] [Abstract][Full Text] [Related]
3. Cationic lipid-based delivery system for systemic cancer gene therapy.
Anwer K; Meaney C; Kao G; Hussain N; Shelvin R; Earls RM; Leonard P; Quezada A; Rolland AP; Sullivan SM
Cancer Gene Ther; 2000 Aug; 7(8):1156-64. PubMed ID: 10975676
[TBL] [Abstract][Full Text] [Related]
4. Factors controlling the efficiency of cationic lipid-mediated transfection in vivo via intravenous administration.
Liu F; Qi H; Huang L; Liu D
Gene Ther; 1997 Jun; 4(6):517-23. PubMed ID: 9231067
[TBL] [Abstract][Full Text] [Related]
5. In vivo gene transfection via intravitreal injection of cationic liposome/plasmid DNA complexes in rabbits.
Kawakami S; Harada A; Sakanaka K; Nishida K; Nakamura J; Sakaeda T; Ichikawa N; Nakashima M; Sasaki H
Int J Pharm; 2004 Jul; 278(2):255-62. PubMed ID: 15196630
[TBL] [Abstract][Full Text] [Related]
6. A hydroxyethylated cholesterol-based cationic lipid for DNA delivery: effect of conditioning.
Percot A; Briane D; Coudert R; Reynier P; Bouchemal N; Lièvre N; Hantz E; Salzmann JL; Cao A
Int J Pharm; 2004 Jun; 278(1):143-63. PubMed ID: 15158957
[TBL] [Abstract][Full Text] [Related]
7. Gamma-polyglutamic acid-coated vectors for effective and safe gene therapy.
Kurosaki T; Kitahara T; Kawakami S; Higuchi Y; Yamaguchi A; Nakagawa H; Kodama Y; Hamamoto T; Hashida M; Sasaki H
J Control Release; 2010 Mar; 142(3):404-10. PubMed ID: 19931327
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and characterization of long chain alkyl acyl carnitine esters. Potentially biodegradable cationic lipids for use in gene delivery.
Wang J; Guo X; Xu Y; Barron L; Szoka FC
J Med Chem; 1998 Jun; 41(13):2207-15. PubMed ID: 9632353
[TBL] [Abstract][Full Text] [Related]
9. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
O'Malley BW; Li D; McQuone SJ; Ralston R
Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147
[TBL] [Abstract][Full Text] [Related]
10. Liposomal lipid and plasmid DNA delivery to B16/BL6 tumors after intraperitoneal administration of cationic liposome DNA aggregates.
Reimer DL; Kong S; Monck M; Wyles J; Tam P; Wasan EK; Bally MB
J Pharmacol Exp Ther; 1999 May; 289(2):807-15. PubMed ID: 10215656
[TBL] [Abstract][Full Text] [Related]
11. Intratumoral pharmacokinetics and in vivo gene expression of naked plasmid DNA and its cationic liposome complexes after direct gene transfer.
Nomura T; Nakajima S; Kawabata K; Yamashita F; Takakura Y; Hashida M
Cancer Res; 1997 Jul; 57(13):2681-6. PubMed ID: 9205077
[TBL] [Abstract][Full Text] [Related]
12. Mannose receptor-mediated gene transfer into macrophages using novel mannosylated cationic liposomes.
Kawakami S; Sato A; Nishikawa M; Yamashita F; Hashida M
Gene Ther; 2000 Feb; 7(4):292-9. PubMed ID: 10694809
[TBL] [Abstract][Full Text] [Related]
13. Cationic liposomes-mediated plasmid DNA delivery in murine hepatitis induced by carbon tetrachloride.
Yoshioka T; Yoshida S; Kurosaki T; Teshima M; Nishida K; Nakamura J; Nakashima M; To H; Kitahara T; Sasaki H
J Liposome Res; 2009; 19(2):141-7. PubMed ID: 19235544
[TBL] [Abstract][Full Text] [Related]
14. Novel cationic solid lipid nanoparticles enhanced p53 gene transfer to lung cancer cells.
Choi SH; Jin SE; Lee MK; Lim SJ; Park JS; Kim BG; Ahn WS; Kim CK
Eur J Pharm Biopharm; 2008 Mar; 68(3):545-54. PubMed ID: 17881199
[TBL] [Abstract][Full Text] [Related]
15. The role of dioleoylphosphatidylethanolamine (DOPE) in targeted gene delivery with mannosylated cationic liposomes via intravenous route.
Hattori Y; Suzuki S; Kawakami S; Yamashita F; Hashida M
J Control Release; 2005 Nov; 108(2-3):484-95. PubMed ID: 16181701
[TBL] [Abstract][Full Text] [Related]
16. Development of cationic liposome formulations for intratracheal gene therapy of early lung cancer.
Zou Y; Zong G; Ling YH; Perez-Soler R
Cancer Gene Ther; 2000 May; 7(5):683-96. PubMed ID: 10830716
[TBL] [Abstract][Full Text] [Related]
17. Biodistribution and transgene expression with nonviral cationic vector/DNA complexes in the lungs.
Bragonzi A; Dina G; Villa A; Calori G; Biffi A; Bordignon C; Assael BM; Conese M
Gene Ther; 2000 Oct; 7(20):1753-60. PubMed ID: 11083497
[TBL] [Abstract][Full Text] [Related]
18. Comparison between intratracheal and intravenous administration of liposome-DNA complexes for cystic fibrosis lung gene therapy.
Griesenbach U; Chonn A; Cassady R; Hannam V; Ackerley C; Post M; Tanswell AK; Olek K; O'Brodovich H; Tsui L-C
Gene Ther; 1998 Feb; 5(2):181-8. PubMed ID: 9578837
[TBL] [Abstract][Full Text] [Related]
19. Biodistribution and gene expression of lipid/plasmid complexes after systemic administration.
Mahato RI; Anwer K; Tagliaferri F; Meaney C; Leonard P; Wadhwa MS; Logan M; French M; Rolland A
Hum Gene Ther; 1998 Sep; 9(14):2083-99. PubMed ID: 9759935
[TBL] [Abstract][Full Text] [Related]
20. Growth inhibition of the pulmonary metastatic tumors by systemic delivery of the p27 kip1 gene using lyophilized lipid-polycation-DNA complexes.
Sun X; Zhang HW; Zhang ZR
J Gene Med; 2009 Jun; 11(6):535-44. PubMed ID: 19326369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]